Search

Researchers at Wayne State University have conducted a study on the use of eravacycline, a synthetic fluorocycline antibiotic, in U.S. hospitals. The study analyzed data from 19 medical centers across the country between October 2018 and August 2022. The results showed that eravacycline was effective in treating a broad range of Gram-negative and Gram-positive bacteria, including multidrug-resistant strains. The study also found that eravacycline had a low rate of adverse effects. This research provides valuable insights into the real-world application of eravacycline and its potential in addressing the challenge of multidrug-resistant bacterial infections. [Extracted from the article]